Cargando…

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

Islet amyloidosis by IAPP contributes to pancreatic β-cell death in diabetes, but the nature of toxic IAPP species remains elusive. Using concurrent time-resolved biophysical and biological measurements, we define the toxic species produced during IAPP amyloid formation and link their properties to...

Descripción completa

Detalles Bibliográficos
Autores principales: Abedini, Andisheh, Plesner, Annette, Cao, Ping, Ridgway, Zachary, Zhang, Jinghua, Tu, Ling-Hsien, Middleton, Chris T, Chao, Brian, Sartori, Daniel J, Meng, Fanling, Wang, Hui, Wong, Amy G, Zanni, Martin T, Verchere, C Bruce, Raleigh, Daniel P, Schmidt, Ann Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940161/
https://www.ncbi.nlm.nih.gov/pubmed/27213520
http://dx.doi.org/10.7554/eLife.12977
_version_ 1782442109880500224
author Abedini, Andisheh
Plesner, Annette
Cao, Ping
Ridgway, Zachary
Zhang, Jinghua
Tu, Ling-Hsien
Middleton, Chris T
Chao, Brian
Sartori, Daniel J
Meng, Fanling
Wang, Hui
Wong, Amy G
Zanni, Martin T
Verchere, C Bruce
Raleigh, Daniel P
Schmidt, Ann Marie
author_facet Abedini, Andisheh
Plesner, Annette
Cao, Ping
Ridgway, Zachary
Zhang, Jinghua
Tu, Ling-Hsien
Middleton, Chris T
Chao, Brian
Sartori, Daniel J
Meng, Fanling
Wang, Hui
Wong, Amy G
Zanni, Martin T
Verchere, C Bruce
Raleigh, Daniel P
Schmidt, Ann Marie
author_sort Abedini, Andisheh
collection PubMed
description Islet amyloidosis by IAPP contributes to pancreatic β-cell death in diabetes, but the nature of toxic IAPP species remains elusive. Using concurrent time-resolved biophysical and biological measurements, we define the toxic species produced during IAPP amyloid formation and link their properties to induction of rat INS-1 β-cell and murine islet toxicity. These globally flexible, low order oligomers upregulate pro-inflammatory markers and induce reactive oxygen species. They do not bind 1-anilnonaphthalene-8-sulphonic acid and lack extensive β-sheet structure. Aromatic interactions modulate, but are not required for toxicity. Not all IAPP oligomers are toxic; toxicity depends on their partially structured conformational states. Some anti-amyloid agents paradoxically prolong cytotoxicity by prolonging the lifetime of the toxic species. The data highlight the distinguishing properties of toxic IAPP oligomers and the common features that they share with toxic species reported for other amyloidogenic polypeptides, providing information for rational drug design to treat IAPP induced β-cell death. DOI: http://dx.doi.org/10.7554/eLife.12977.001
format Online
Article
Text
id pubmed-4940161
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-49401612016-07-13 Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics Abedini, Andisheh Plesner, Annette Cao, Ping Ridgway, Zachary Zhang, Jinghua Tu, Ling-Hsien Middleton, Chris T Chao, Brian Sartori, Daniel J Meng, Fanling Wang, Hui Wong, Amy G Zanni, Martin T Verchere, C Bruce Raleigh, Daniel P Schmidt, Ann Marie eLife Biochemistry Islet amyloidosis by IAPP contributes to pancreatic β-cell death in diabetes, but the nature of toxic IAPP species remains elusive. Using concurrent time-resolved biophysical and biological measurements, we define the toxic species produced during IAPP amyloid formation and link their properties to induction of rat INS-1 β-cell and murine islet toxicity. These globally flexible, low order oligomers upregulate pro-inflammatory markers and induce reactive oxygen species. They do not bind 1-anilnonaphthalene-8-sulphonic acid and lack extensive β-sheet structure. Aromatic interactions modulate, but are not required for toxicity. Not all IAPP oligomers are toxic; toxicity depends on their partially structured conformational states. Some anti-amyloid agents paradoxically prolong cytotoxicity by prolonging the lifetime of the toxic species. The data highlight the distinguishing properties of toxic IAPP oligomers and the common features that they share with toxic species reported for other amyloidogenic polypeptides, providing information for rational drug design to treat IAPP induced β-cell death. DOI: http://dx.doi.org/10.7554/eLife.12977.001 eLife Sciences Publications, Ltd 2016-05-23 /pmc/articles/PMC4940161/ /pubmed/27213520 http://dx.doi.org/10.7554/eLife.12977 Text en © 2016, Abedini et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Biochemistry
Abedini, Andisheh
Plesner, Annette
Cao, Ping
Ridgway, Zachary
Zhang, Jinghua
Tu, Ling-Hsien
Middleton, Chris T
Chao, Brian
Sartori, Daniel J
Meng, Fanling
Wang, Hui
Wong, Amy G
Zanni, Martin T
Verchere, C Bruce
Raleigh, Daniel P
Schmidt, Ann Marie
Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title_full Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title_fullStr Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title_full_unstemmed Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title_short Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
title_sort time-resolved studies define the nature of toxic iapp intermediates, providing insight for anti-amyloidosis therapeutics
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940161/
https://www.ncbi.nlm.nih.gov/pubmed/27213520
http://dx.doi.org/10.7554/eLife.12977
work_keys_str_mv AT abediniandisheh timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT plesnerannette timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT caoping timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT ridgwayzachary timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT zhangjinghua timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT tulinghsien timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT middletonchrist timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT chaobrian timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT sartoridanielj timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT mengfanling timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT wanghui timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT wongamyg timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT zannimartint timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT vercherecbruce timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT raleighdanielp timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics
AT schmidtannmarie timeresolvedstudiesdefinethenatureoftoxiciappintermediatesprovidinginsightforantiamyloidosistherapeutics